This Viewpoint questions a recently published treatment algorithm for patients with HER2-amplified metastatic colorectal cancer and proposes alternative timing for HER2 testing and HER2-directed therapies.
No takes yet. Share an insight, caveat, or question.
Bregni et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: